A Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistamines
PHASE3
This is a Phase 3, parallel group, placebo-controlled, double-blind, confir...
A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa (RECHARGE 1)
PHASE3
The purpose of this study is to establish the efficacy, safety, and tolerab...
An Extension Study of Long-term Efficacy, Safety and Tolerability of Remibrutinib in Chronic Spontaneous Urticaria Patients Who Completed Preceding Studies With Remibrutinib
PHASE3
The purpose of this extension study is to collect long-term efficacy, safet...